These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 8207983

  • 1. In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemia.
    Cornic M, Delva L, Castaigne S, Lefebvre P, Balitrand N, Degos L, Chomienne C.
    Leukemia; 1994 Jun; 8(6):914-7. PubMed ID: 8207983
    [Abstract] [Full Text] [Related]

  • 2. In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemia.
    Cornic M, Delva L, Castaigne S, Lefebvre P, Balitrand N, Degos L, Chomienne C.
    Leukemia; 1994 Jun; 8 Suppl 2():S16-9. PubMed ID: 7815831
    [Abstract] [Full Text] [Related]

  • 3. Constitutive expression of cellular retinoic acid binding protein II and lack of correlation with sensitivity to all-trans retinoic acid in acute promyelocytic leukemia cells.
    Zhou DC, Hallam SJ, Lee SJ, Klein RS, Wiernik PH, Tallman MS, Gallagher RE.
    Cancer Res; 1998 Dec 15; 58(24):5770-6. PubMed ID: 9865735
    [Abstract] [Full Text] [Related]

  • 4. Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells.
    Delva L, Cornic M, Balitrand N, Guidez F, Micléa JM, Delmer A, Teillet F, Fenaux P, Castaigne S, Degos L.
    Blood; 1993 Oct 01; 82(7):2175-81. PubMed ID: 8400267
    [Abstract] [Full Text] [Related]

  • 5. Poor response to all-trans retinoic acid therapy in a t(11;17) PLZF/RAR alpha patient.
    Guidez F, Huang W, Tong JH, Dubois C, Balitrand N, Waxman S, Michaux JL, Martiat P, Degos L, Chen Z.
    Leukemia; 1994 Feb 01; 8(2):312-7. PubMed ID: 8309256
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z, Cholovitsh M, Elezovitsh I, Vidovitsh A, Radoshevitsh-Radojkovitsh N, Boshkovitsh D, Novak A, Basara N.
    Srp Arh Celok Lek; 1995 Feb 01; 123(11-12):279-85. PubMed ID: 16296239
    [Abstract] [Full Text] [Related]

  • 9. All-trans retinoic acid modulates the retinoic acid receptor-alpha in promyelocytic cells.
    Chomienne C, Balitrand N, Ballerini P, Castaigne S, de Thé H, Degos L.
    J Clin Invest; 1991 Dec 01; 88(6):2150-4. PubMed ID: 1661301
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. All-trans-retinoic acid treatment and retinoic acid receptor alpha gene rearrangement in acute promyelocytic leukemia: a model for differentiation therapy.
    Degos L.
    Int J Cell Cloning; 1992 Mar 01; 10(2):63-9. PubMed ID: 1312109
    [Abstract] [Full Text] [Related]

  • 13. [Treatment of acute promyelocytic leukemia by all trans retinoic acid].
    Castaigne S, Degos L.
    C R Seances Soc Biol Fil; 1995 Mar 01; 189(4):515-20. PubMed ID: 8564565
    [Abstract] [Full Text] [Related]

  • 14. Modulation of IL-8, IL-1 beta, and G-CSF secretion by all-trans retinoic acid in acute promyelocytic leukemia.
    Dubois C, Schlageter MH, de Gentile A, Balitrand N, Toubert ME, Krawice I, Fenaux P, Castaigne S, Najean Y, Degos L.
    Leukemia; 1994 Oct 01; 8(10):1750-7. PubMed ID: 7523800
    [Abstract] [Full Text] [Related]

  • 15. Therapy of acute promyelocytic leukemia: all-trans retinoic acid and beyond.
    Tallman MS.
    Leukemia; 1998 Sep 01; 12 Suppl 1():S37-40. PubMed ID: 9777894
    [Abstract] [Full Text] [Related]

  • 16. Long-term survival and prognostic study in acute promyelocytic leukemia treated with all-trans-retinoic acid, chemotherapy, and As2O3: an experience of 120 patients at a single institution.
    Hu J, Shen ZX, Sun GL, Chen SJ, Wang ZY, Chen Z.
    Int J Hematol; 1999 Dec 01; 70(4):248-60. PubMed ID: 10643151
    [Abstract] [Full Text] [Related]

  • 17. All-trans-retinoic acid in acute promyelocytic leukemia and its potential in other hematologic malignancies.
    Tallman MS.
    Semin Hematol; 1994 Oct 01; 31(4 Suppl 5):38-48. PubMed ID: 7831584
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Retinoic acid and acute promyelocytic leukemia: a model of targetting treatment for human cancer.
    Chen Z, Chen SJ, Wang ZY.
    C R Acad Sci III; 1994 Dec 01; 317(12):1135-41. PubMed ID: 7697468
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.